EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lutein Attenuates Parkinson’s Disease Progression by Regulating Mitochondrial Function via the TRIM31/Drp1 Signaling Pathway

Jiabin Duan, Wenbin Duan, Xiaomin Pu, Changdi Ma, Huai Huang, Zhenghu Xu

Journal of Integrative Neuroscience · 2026

DOI: 10.31083/jin45758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, 2026. Verfasst von Jiabin Duan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Baoshan Municipal People's Hospital, 678000 Baoshan, Yunnan, China. Hauptthemen laut MEDLINE: Mitochondria, Lutein, Signal Transduction, Ubiquitin-Protein Ligases. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Doctoral Research Program of the Second Affiliated Hospital of Kunming Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitochondrial dysfunction is closely associated with the pathogenesis of Parkinson’s disease (PD). Lutein has been shown to exert protective effects in neurological disorders. This study aimed to investigate the ameliorative effects of lutein on mitochondrial function in PD and its underlying molecular mechanisms.

Methods

Animal and cellular PD models were established by intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice and treatment of SH-SY5Y cells with 1-methyl-4-phenylpyridinium ion (MPP+), respectively. Motor function was assessed using the rotarod, adhesive removal, and pole tests. Mitochondrial function was evaluated using MitoSOX Red staining, JC-1 staining, and adenosine triphosphate (ATP) content measurement. Western blotting and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were used to measure the levels of relevant proteins and mRNA.

Results

Lutein significantly ameliorated MPTP-induced motor dysfunction in PD mice, increased the number of tyrosine hydroxylase (TH)-positive neurons, and alleviated damage to striatal brain tissue. At the cellular level, lutein significantly suppressed MPP+-induced apoptosis of SH-SY5Y cells, upregulated the expression of B-cell lymphoma-2 (Bcl-2), and downregulated the expression of Bcl-2-associated X protein (Bax) and cleaved caspase-3. Additionally, lutein significantly reduced reactive oxygen species (ROS) levels, restored mitochondrial membrane potential, increased ATP levels, and increased the activity of mitochondrial respiratory chain complex I. At the molecular level, lutein promoted the ubiquitination of dynamin-related protein 1 (Drp1), whose degradation was impaired in the PD model. This effect was mediated by the E3 ubiquitin ligase Tripartite Motif-containing protein 31 (TRIM31), whose expression was downregulated in the disease state. Functional experiments confirmed that overexpression of TRIM31 enhanced Drp1 ubiquitination and improved mitochondrial function, whereas TRIM31 knockdown partially attenuated the therapeutic effects of lutein.

Conclusion

In summary, this study revealed, for the first time, that lutein alleviates PD progression by increasing Drp1 ubiquitination and degradation via TRIM31 transcription and translation, ultimately improving neuronal mitochondrial function. These findings not only elucidate a novel mechanism underlying lutein’s neuroprotective effect but also identify a potential therapeutic target and offer a new strategy for PD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaLuteinSignal TransductionUbiquitin-Protein LigasesDynaminsParkinsonian DisordersTripartite Motif ProteinsNeuroprotective AgentsAnimalsMaleMiceHumansMice, Inbred C57BLDisease ProgressionDisease Models, AnimalCell Line, Tumor

Stichwörter der Autor:innen

Drp1Parkinson’s diseaseTRIM31luteinmitochondrial functionneurons

Substanzen

LuteinUbiquitin-Protein LigasesDynaminsTripartite Motif ProteinsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, Baoshan Municipal People's Hospital, 678000 Baoshan, Yunnan, China.
  • Department of Neurology, Hebei PetroChina Central Hospital, 065000 Langfang, Hebei, China.
  • Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, 650000 Kunming, Yunnan, China.

Förderung

  • Doctoral Research Program of the Second Affiliated Hospital of Kunming Medical University

Zitieren

APA

Duan, J., Duan, W., Pu, X., Ma, C., Huang, H., & Xu, Z. (2026). Lutein Attenuates Parkinson’s Disease Progression by Regulating Mitochondrial Function via the TRIM31/Drp1 Signaling Pathway. Journal of Integrative Neuroscience. https://doi.org/10.31083/jin45758

Vancouver

Duan J, Duan W, Pu X, Ma C, Huang H, Xu Z. Lutein Attenuates Parkinson’s Disease Progression by Regulating Mitochondrial Function via the TRIM31/Drp1 Signaling Pathway. Journal of Integrative Neuroscience. 2026. doi:10.31083/jin45758

BibTeX
@article{Duan2026,
  author = {Duan, Jiabin and Duan, Wenbin and Pu, Xiaomin and Ma, Changdi and Huang, Huai and Xu, Zhenghu},
  title = {Lutein Attenuates Parkinson’s Disease Progression by Regulating Mitochondrial Function via the TRIM31/Drp1 Signaling Pathway},
  journal = {Journal of Integrative Neuroscience},
  year = {2026},
  doi = {10.31083/jin45758}
}
Kostenlos starten →